OraSure Technologies (NASDAQ:OSUR) Stock Breaks Below 200 Day Moving Average - Time to Sell?

Key Points

• OraSure Technologies shares fell below their 200-day moving average, trading as low as $3.46 versus the $3.52 average and last changing hands at $3.45.
• Analyst sentiment is mixed: one analyst rates the stock Strong Buy, two rate it Hold and one rates it Sell. The consensus rating is Hold, with a $3.00 price target.
• Institutional investors own a substantial 93.5% of the company, while hedge-fund activity included new positions and increased holdings during the second quarter.

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $3.52 and traded as low as $3.46. OraSure Technologies shares last traded at $3.45, with a volume of 861,615 shares trading hands.

Wall Street Analysts Forecast Growth

OSUR has been the subject of several recent analyst reports. Wall Street Zen raised shares of OraSure Technologies from a "sell" rating to a "hold" rating in a report on Monday, August 10th. Zacks Research upgraded shares of OraSure Technologies to a "hold" rating in a report on Friday, October 2nd. Weiss Ratings reissued a "sell (d-)" rating on shares of OraSure Technologies in a research report on Tuesday, September 1st. Finally, Craig Hallum raised shares of OraSure Technologies to a "strong-buy" rating in a research report on Friday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $3.00.

OraSure Technologies Stock Down 12.4%

The stock has a market capitalization of $237.95 million, a P/E ratio of -5.00 and a beta of 1.03. The business has a fifty day moving average price of $3.75 and a 200-day moving average price of $3.52.

Hedge Funds Weigh In On OraSure Technologies

A number of hedge funds have recently bought and sold shares of the business. Headlands Technologies LLC bought a new stake in shares of OraSure Technologies in the second quarter worth approximately $67,000. Susquehanna International Group LLP raised its holdings in shares of OraSure Technologies by 29.4% during the second quarter. Susquehanna International Group LLP now owns 198,779 shares of the medical instruments supplier's stock valued at $887,000 after purchasing an additional 45,169 shares during the last quarter. Two Sigma Securities LLC bought a new position in OraSure Technologies during the second quarter valued at approximately $55,000. Cannell Capital LLC bought a new position in OraSure Technologies during the second quarter valued at approximately $6,366,289. Finally, Public Employees Retirement System of Ohio bought a new position in OraSure Technologies during the second quarter valued at approximately $416,000. Hedge funds and other institutional investors own 93.50% of the company's stock.

OraSure Technologies Company Profile

OraSure Technologies, Inc develops, manufactures and markets diagnostic products and specimen-collection technologies used by healthcare providers, laboratories, researchers and consumers. The company focuses on making testing more accessible through products that support decentralized, point-of-care and at-home testing, as well as laboratory-based molecular and diagnostic workflows.

Its portfolio has included the OraQuick line of rapid diagnostic tests, including oral-fluid tests for HIV and hepatitis C, along with other infectious-disease testing products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.